本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

70.12
-0.1000-0.14%
盤後70.120.00000.00%16:10 EDT
成交量:37.08萬
成交額:2,601.99萬
市值:29.77億
市盈率:-44.10
高:71.37
開:69.06
低:69.01
收:70.22
52周最高:85.25
52周最低:38.51
股本:4,244.91萬
流通股本:3,035.16萬
量比:0.72
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.5900
每股收益(LYR):-1.5900
淨資產收益率:-23.39%
總資產收益率:-9.45%
市淨率:8.67
市盈率(LYR):-44.10

資料載入中...

2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2022/12/07

重要事件披露

8-K - Current report
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/12

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report